Sign in
4

Changes in Ownership

IN8BIO, INC. Filed Acc 0001209191-23-058716

Chief Operating Officer acquired 12,295 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Rochlin Kate Chief Operating Officer 2023-12-13 Grant or award +12,295 17,558 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Rochlin Kate Chief Operating Officer 2023-12-13 Grant or award · Series A Warrants (right to buy) +12,295 12,295 D: show line 2 in the form
Rochlin Kate Chief Operating Officer 2023-12-13 Grant or award · Series B Warrants (right to buy) +12,295 12,295 D: show line 3 in the form
Loading xslF345X05/doc4.xml…